Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. TaiDoc Technology's Revenue for the
three
months ended in Dec. 2025 was NT$1,028 Mil. TaiDoc Technology's average Accounts Receivable for the
three
months ended in Dec. 2025 was NT$922 Mil.
Hence, TaiDoc Technology's Receivables Turnover for the
three
months ended in Dec. 2025 was 1.12.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
TaiDoc Technology Receivables Turnover Related Terms
TaiDoc Technology Receivables Turnover Historical Data
* Premium members only.
The historical data trend for TaiDoc Technology's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4736 vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, TaiDoc Technology's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiDoc Technology Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TaiDoc Technology's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where TaiDoc Technology's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiDoc Technology (TPE:4736) has a Receivables Turnover of 1.12 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on TaiDoc Technology and its competitors. According to the industry distribution chart, TaiDoc Technology ranks #553 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 68.2%.
Is TaiDoc Technology's Receivables Turnover too high?
TaiDoc Technology's current Receivables Turnover is 1.12. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. TaiDoc Technology's value of 1.12 is 79.7% below this industry median. Based on the distribution chart, TaiDoc Technology ranks #553 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, TaiDoc Technology has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TaiDoc Technology ranks #553 out of 811 companies for Receivables Turnover. This places TaiDoc Technology in the lower half of its industry. The industry median Receivables Turnover is 5.51. TaiDoc Technology's value of 1.12 is 79.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current Receivables Turnover of 1.12 is 79.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on TaiDoc Technology and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current Receivables Turnover is 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$110.24, compared to a current price of NT$129.50 — trading 17.5% above its estimated fair value. The current Receivables Turnover is 1.12 and 79.7% below the Medical Devices & Instruments industry median of 5.51. TaiDoc Technology's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current Receivables Turnover is 1.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiDoc Technology (TPE:4736) Overvalued in 2026?
Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued.
The current stock price of NT$129.50 is trading 17.5% above its estimated GF Value™ of NT$110.24.
GuruFocus considers TaiDoc Technology to be Modestly Overvalued.
Key valuation signals for TPE:4736:
Receivables Turnover: 1.12
GF Value™: NT$110.24 vs. price of NT$129.50 (17.5% above fair value)
Industry Position: 79.7% below the Medical Devices & Instruments median (#553 of 811)
No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
69GF Score
Get the complete analysis for TPE:4736
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4736 has been successfully added to your 
